Experts for Media - Pediatric Hematology/Oncology

David M. Loeb, MD, Ph.D

Chief, Division of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation, Children’s Hospital at Montefiore and associate professor, Pediatrics and Developmental and Molecular Biology, Albert Einstein College of Medicine

Dr. Loeb is a leading pediatric oncologist and NIH-funded researcher.  He has extensive expertise in sarcoma research and clinical care and is a bone marrow transplantation specialist. Dr. Loeb’s research spans the spectrum from basic and translational studies to clinical trials using novel therapies.

Areas of Expertise

  • Childhood cancer 
  • Treatments for childhood cancer including bone marrow transplant
  • Musculoskeletal Tumors
  • Sarcoma

Selected Media Coverage

Deepa Manwani, MD

Director, Sickle Cell Disease Program, The Children’s Hospital at Montefiore

Associate Professor of Clinical Pediatrics (Hematology & Oncology), Albert Einstein College of Medicine

Dr. Manwani is a pediatric hematologist who leads the sickle cell team at CHAM. The team offers treatment and support for young children and teens with sickle cell disease and their families, including weekly support groups and an annual Sickle Cell Awareness Day event focused on new research and strategies for living with this disease.

Areas of Expertise

  • Sickle cell disease

Selected Media Coverage

U.S. News & World Report

David Geller, MD    David S. Geller                                                                 

Director, Sarcoma and Soft-Tissue Oncology Service, Montefiore
Assistant Professor, Orthopaetic Surgery, Albert Einstein College of Medicine
Assistant Professor, Pediatrics (Hematology & Oncology), Albert Einstein College of Medicine

Dr. Geller is an orthopaedic surgeon specializing in musculoskeletal oncology and joint replacement, and his practice encompasses adult and pediatric patients. Dr. Geller’s research interests include surface receptor expression in osteosarcoma and potential targeted therapies for the treatment of osteosarcoma. He has developed a novel murine xenograft model for osteosarcoma for the evaluation of surgical margins in osseous tumor surgery. His research additionally includes allograft bone reconstruction techniques, resonance frequency changes during joint reconstruction and pain management in the elderly orthopaedic population.

Areas of Expertise

  • Musculoskeletal oncology and joint replacement (adult and pediatric).
  • Limb sparing surgical techniques
  • Innovative surgical treatments and patient-tailored implants for those who suffer from osteosarcoma and other primary bone tumors

Selected Media Coverage

NY Daily News, Montefiore

Newsroom